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Pathway Verification in TX-TL 
Linear DNA encoding individual enzymes are added into TX-TL reactions to verify enzyme 
expression. End products of TX-TL reactions are directly used for polyacrylamide gel 
electrophoresis with sodium dodecyl sulfate (SDS-PAGE) preparation, and all enzymes of the 
BDO pathway show up on the gel at expected sizes. Below Figure S1 shows an SDS-PAGE gel 
with the expression of relevant pathway enzymes. 0.5 ul of TX-TL reactions are used for 
analyzing enzyme expression. Background proteins are proteins extracted during cell lysis.  
 
	
 
Figure S1: Verifying enzyme expression using SDS-PAGE gel: From left to right are negative 
control (NEG), succinyl-CoA synthetase (sucCD, two subunits α and β at 29.6 kDa and 41.4 
kDa1), CoA-dependent succinate semialdehyde dehydrogenase (sucD-035, 50.2 kDa), 4-
hydroxybutyryl-CoA transferase (cat2-034, 48.0 kDa), 4-hydroxybutyryl-CoA reductase (ald-
025B, 52.1 kDa), 4-hydroxybutyrate dehydrogenase (4hbd-036, 41.3 kDa) alcohol 
dehydrogenase (adh-012, 43.1 kDa), 2-oxoglutarate decarboxylase (sucA, 100kDa), 4-
hydroxybutyryl-CoA reductase (ald(002c), 95.3kDa), and protein ladder.  
 
A range of cofactor concentration were tested for improved BDO production. Results are shown 
in Figure S2.  In a typical TX-TL reaction, 0.26 mM of coA has been added as part of the buffer, 
1 mM of NADPH, 1 mM of acetyl-coA, and 1 mM of NADH are added. Here, we vary the 
concentration of coA, acetyl-coA, NADP, and NADPH one at a time to understand the effect of 
these cofactors have on the metabolite production. The metric here is to compare downstream 
metabolite production versus upstream metabolite production. Mainly, we are comparing the 
total production of BDO and GBL to the total production of GABA and 4HB. Figure S2 shows 
that the lack of coA or acetyl-coA leads to the accumulation of upstream metabolites. When 
more NADPH is added to the system, more downstream metabolites are produced.    
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Figure S2: Testing cofactor concentration for improved BDO production: a. coA b. acetyl-coA 
c. NADP d. NADPH, blue bar—sum of the concentration of BDO and GBL, orange bar—sum of 
the concentration of 4HB and γ-aminobutyric acid (GABA). Error bars show one standard 
deviation for n ≥ 3 independent experiments.  
 
System-level Studies of TX-TL 
The production of acetate is very prominent in the TX-TL system. The production of acetate 
through the BDO pathway enzymes does not account for the acetate measured in the system. The 
conversion from 3-PGA or glutamate to acetate regenerates cofactor such as NADH, NADPH, 
ATP, and acetyl-coA, which explains the significant production of acetate.2 Figure S3b and 
Figure S3c below shows the ratio of NADPH/NADP and NADH/NAD. The energy charge is 
also calculated to capture resource limitation of the system (shown in Figure S3a). The 
production of HB-coA in Figure S3d shows the peak at 6 hours, which is when BDO production 
starts to plateau.  
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Figure S3: Metabolomics in TX-TL: a. Energy Charge over time b. Ratio of NADPH/NADP c. 
Ratio of NADH/NAD d. HB-coA concentration over time  
 
Genomatica has previously developed antibodies specifically for enzyme ald and adh. Without 
inserting additional protein tags, we analyze enzyme expression profile without interfering 
pathway dynamics. Below in Figure S4 shows the SDS-PAGE (top) and Western blot (bottom) 
that analyzed the protein dynamics over time. The protein bands in the Western blot show 
unspecific binding at 30 kDa and 80 kDa. However, the separation between target protein band 
and the unspecific band are large enough for protein expression analysis. As shown, the ald (C) 
is about 60 kDa, where the adh (C) is about 40 kDa. We analyzed the same sample in two 
different ways: 1) add TX-TL reaction directly for protein gel analysis and 2) centrifuge samples 
and add soluble fraction for protein gel analysis. The protein analysis shows that TX-TL is a 
good expression system where there is a good amount of protein remains in the soluble fraction. 
Here we can also visually identify that protein expression peaks at 8 hours.  
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Figure S4: ald (C) and adh (C) expression over time in TX-TL. Top: SDS-PAGE gel. Bottom: 
Western blot. Both images are separated by total sample (left) and soluble protein fraction 
(right). ald (C) and adh (C) are 60kDa and 40 kDa respectively.    
 
Design Space Exploration  
We have picked elements from Chen et al.’s terminator library:3 ECK120033736 (164.6x), 
ECK120015440 (119.21x), and ECK120010799 (101.05x). These terminators have been 
previously tested for similar expression levels. We use plasmids pZ33s and pZS*23s previously 
published.4 Detailed constructs are shown in Figure S5. We use BCD22 for enzymes on the 
pZA33s plasmid. BCD 22 is the UTR that gives weak protein expression, and pZA33s has p15A 
as a replication of origin. pZS*23S has SC101 as a replication of origin. The pZA33s plasmid 
has a slightly higher copy number than the pZS*23S. For experiments done during design space 
exploration, 5 nM of the pZA33s is added, and 3 nM of pZS*23s is added. The ratio used in TX-
TL is an attempt to reflect the copy number ratio in vivo. PZA33s contains kanamycin resistance, 
and pZS*23s contains chloramphenicol resistance. While kanamycin kills bacteria by binding to 
30S ribosomal subunit and causes misreading of t-RNA, chloramphenicol kills bacteria by 
binding to 50S ribosomal subunit and prevents peptide bond formation.5 To better map TX-TL to 
in vivo, it may also be a good idea to switch to a different set of antibiotics.  
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Figure S5: Construct assembly for design space exploration. Left: non-bottleneck enzymes 
sucD, cat2, and 4hbd on pZA33s. Right: bottleneck enzymes ald and adh on pZS*23s 
 
Constructs are designed to mimic the ratio of linear DNA encoding pathway enzymes. The 
metabolic profile of TX-TL reaction added with plasmid DNA is similar to the metabolic profile 
of TX-TL reaction added with linear DNA. Table S1 shows the constructs with varying ald (C) 
and adh (C) strength. The numbers in the table are the order of which the samples are loaded 
onto the protein gel for expression comparison between TX-TL and in vivo.  
 
Sample Order  adh Expression Level 
Strong Medium Weak 
al
d 
Ex
pr
es
si
on
 
Le
ve
l 
Strong 1 2 3 
Medium 4 5 6 
Weak 7 8 9 
 
Table S1: Constructs with varying ald (C) and adh (C) expression levels: The numbers in the 
table are the order in which samples are loaded onto protein gels for expression comparison 
shown in Figure S7.  
 
Samples for metabolite analysis and protein expression analysis are collected after 16 hours of 
TX-TL reaction. The raw SDS-PAGE and Western blots are shown in Figure S6. Protein ladder 
followed by the negative control are added as the two samples. Constructs with varying adh(C) 
and ald (C) expression levels shown in Table S1 then added by its numerical order. Values 
presented in Figure 3 are intensities of soluble protein from the Western blot, which are 
measured and normalized by the total protein intensities shown in the SDS-PAGE gel. Overall, 
Figure S6b and S6d shows a range of protein expression levels for adh (C) and ald (C). Note 
that there are more unspecific bands in the Western blot for in vivo samples. We have observed 
insoluble proteins in the in vivo samples, which explains the smear on the right side of the 
Western blot shown in Figure S6d. Table S2 lists the parameters from linear regression for data 
shown in Figure 3 c and f. The slope differences in TX-TL indicates that resource limitation 
might have played a role in metabolite production. The strong expression of adh (C) may have 
impacted metabolite production, where too weak of an expression is not enough for metabolite 
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production.  The slope of the linear regression for in vivo data is very similar, which confirms 
that ald (C) is the bottleneck enzyme for the production of BDO.   
 
Figure S6: ald (C) and adh (C) expression in vivo (right: b and d) Vs. in TX-TL (left: a and c). 
Top: SDS-PAGE gel (a and b). Bottom: Western blot (c and d). Each image is separated by total 
sample (left) and soluble protein fraction (right). ald (C) and adh (C) are 60kDa and 40 kDa 
respectively.    
 
Linear Regression Parameters in Figure 3c 
adh Expression  slope intercept 
Strong 5.32 2.09 
Medium  9.52 1.90 
Weak  5.52 1.50 
 
Linear Regression Parameters in Figure 3f 
adh Expression slope intercept 
Strong 0.24 0.94 
Medium 4.49 -0.17 
Weak 6.26 -1.18 
 
Table S2: Slope and Intercept for Linear Regression in Figure 3. 
 
 
Applications of TX-TL 
Enzyme expressions from two of the three enzyme combinations are analyzed. Details are shown 
in Figure S7.  Time-course protein expression (1 hour, 3hours, 5 hours, and 8 hours) of 
sample	 soluble	fraction	
220
120
80
60
40
30
20
ald
adh
150
100
75
50
37
25
20
50
100
a. b.
c. d.
sample	 soluble	fraction	
150
100
75
50
37
25
20
ald
adh
220
120
80
60
40
30
20
50
100
ald
adh
	 S7 
Combination B and Combination C are analyzed. From left to right of the Western blot, a 
negative control was added first, and time-course samples from Combination B and Combination 
C were added. To the left of the Western blot is the relative ald expression over time. Note that 
enzymes from Combination C have a strong expression than enzymes from Combination B. Both 
ald and adh from Combination C are enzymes engineered for stability in vitro, while the ones 
from Combination B are wild-type enzymes.  
 
Figure S7: ald and adh expression for ranking pathways in TX-TL. To the left of the ladder are 
samples from total TX-TL reactions, and to the right of the ladder is soluble protein in the 
supernatant fraction of TX-TL reactions.  
 
Characteristics of S138 in vivo 
Metabolomics of S138 in vivo is also performed. Below in Figure S8 shows the production of 
BDO over time. Energy charge (Figure S8b), NADPH/NADP ratio (FigureS8c), and 
NADH/NAD ratio (Figure S8d) are very similar to the ones observed in TX-TL. The pH in vivo 
drops rapidly (Figure S9b), and it is about 4 by the end of 28 hours, where the pH in TX-TL 
stays above 6 during 8-hour reactions. Improvement on the buffer of the in vivo system can help 
improve metabolite production. 
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Figure S8: Characteristics of S138 in vivo: a. BDO production over time b. pH over time c. 
Energy charge over time, d. NADPH/NADP and e. NADH/NAD. For c, d, and e: blue—negative 
control, orange—S138 with the BDO pathway (Data are collected with Construct 4 shown in 
Table S1) 
 
 
Figure S9: pH comparison between TX-TL and in vivo: a. pH measured over time of TX-TL 
samples b. pH measured over time of in vivo samples 
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